DRUG DISCOVERY FOR ONCOLOGY: Predictive Oncology has developed a platform to enable the advancement of oncology candidate compounds into the clinic with a higher probability of success. By incorporating tumor heterogeneity into the early drug discovery process, we can emulate clinical trial diversity challenges at the preclinical stage. Through our proprietary PEDAL platform, compounds are evaluated with primary patient tumor samples and paired with a highly developed and active machine learning system to efficiently drive experiments for more efficient drug discovery. These experiments are highly customizable cell-based assays. FORMULATION SERVICES FOR BIOLOGICS (ANY DISEASE): Our formulation services for biologics include proteins, peptides, VLPs and whole live attenuated virus directed at any disease. Predictive Oncology can help improve the solubility and stability of challenging proteins in 4-6 months with only 20-70 mg of protein.